David Heal has been accepted as an in-person participant at the European Medicines Agency (EMA) meeting ‘EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework’ to be held at the EMA, Amsterdam, The Netherlands, 16th-17th April 2024.
The workshop brings together patients and experts from the healthcare sector, academia, the pharmaceutical industry and regulatory bodies to discuss the opportunities and challenges in developing safe and effective psychedelics for the treatment of a variety of psychiatric conditions. The aim of the workshop is to provide a basis for the development of EU regulatory guidance on the therapeutic use of psychedelics.
The meeting is by invitation only but will be broadcast live. For further details please click here.
DevelRx specialises in the evaluation of the abuse potential of novel psychedelics. If you are attending this workshop and would like to meet David to discuss our services please get in touch.